Evidence map›Paper›PMID 37378850›Full record

ArticleInternational urology and nephrology2024

To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.

Nida Saleem, Humaira Nasir, Fatima Anwar, Maliha Aziz, Kiran Khurshid, Saima Bashir, Asrar Khan

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nida SaleemDepartment of NeCollege of Medicine and Public Health, Flinders University, Sturt Rd, Bedford Park, SA , 5042 , Adelaide, Australia. nidasaa1968@gmail.com.ORCID http://orcid.org/0000-0002-7139-8912
Humaira NasirDepartment of Pathology, Shifa International Hospital, H-8/4, Pitras Bukhari Road, Islamabad, Pakistan.
Fatima AnwarDepartment of Pathology, Shifa International Hospital, H-8/4, Pitras Bukhari Road, Islamabad, Pakistan.
Maliha AzizDepartment of Clinical Research Centre, Shifa International Hospital, Islamabad, Pakistan.ORCID http://orcid.org/0000-0001-8607-2440
Kiran KhurshidDepartment of Nephrology, Shifa International Hospital, H-8/4, Pitras Bukhari Road, Islamabad, Pakistan.
Saima BashirDepartment of Nephrology, Shifa International Hospital, H-8/4, Pitras Bukhari Road, Islamabad, Pakistan.
Asrar KhanDepartment of Nephrology, University of Wollongong, (A) Suite 606, Level 6, 360-364 Crown Street, Wollongong, NSW, 2500, Syndey, Australia.ORCID http://orcid.org/0000-0002-5836-8831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmunoglobulin A Nephropathy (IgAN) is a heterogeneous disorder. Multiple ethnicities conducted studies to assess the effectiveness of the Oxford classification of IgAN in prognostication. However, there is no study on the Pakistani population. We aim to identify its prognostic effectivity in our patients.

methodsWe retrospectively reviewed the medical records of 93 biopsy-proven cases of primary IgAN. We collected the clinical and pathological data at baseline and on follow-ups. The median follow-up period was 12 months. We defined the renal outcome as a ≥ 50% decline in eGFR or end-stage renal disease (ESRD).

resultsOf 93 cases, 67.7% were males with a median age of 29. Glomerulosclerosis was the most prevalent lesion (71%). The median MEST-C was 3. On follow-up, median serum creatinine worsened from 1.92 to 2.2 mg/dL, and median proteinuria reduced from 2.3 g/g to 1.072 g/g. The reported renal outcome was 29%. T and C scores and MEST-C scores above 2 were significantly associated with pre-biopsy eGFR. On Kaplan-Meier analysis, the T and C scores' association was significant with the renal outcome (p-value 0.000 and 0.002). In univariate and multivariate analyses, the association of T-score (p-value 0.000, HR 4.691), total MEST-C score (p-value 0.019), and baseline serum creatinine (p-value 0.036, HR 1.188) were significant with the outcome.

conclusionWe validate the prognostic significance of the Oxford classification. T and C scores, baseline serum creatinine, and total MEST-C score significantly affect the renal outcome. Furthermore, we recommend the inclusion of the total MEST-C score in determining the IgAN prognosis.

Indexed as

Glomerulonephritis, IGAKidney Failure, ChronicAdultCreatinineDisease ProgressionFemaleGlomerular Filtration RateHumansKidneyMalePrognosisRetrospective StudiesCreatinineeGFREnd-stage renal diseaseIgA nephropathyOxford classificationRenal biopsy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.